Who's buying Lycia Therapeutics, Inc.?

LYCA insider buying, 13F and 13D filings

• Oct 27, 2026Form 4 · 10% owner
  Venrock Healthcare Capital Partners III, L.P. (+8 joint): Bought $37.7M on the open market
  2.05M shares at ~$18.41, traded 2026-10-23 to 2026-10-27. Now holds 6.83M shares (stake up 43%).
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.